H1B Report
Side-by-side comparison

Bioinfo Systems, LLC vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Bioinfo Systems, LLC
CTRank #FEIN 55-0909860
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricBioinfo Systems, LLCDeloitte Consulting LLP
Total filings56280,813
Certified %91.99%98.23%
Denied %3.56%1.09%
Withdrawn %4.27%0.61%
Cert-withdrawn %0.18%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateCTPA

Outcomes — Bioinfo Systems, LLC

DOL case-status mix.

Outcome breakdown: Certified 92.0%, Cert-withdrawn 0.2%, Withdrawn 4.3%, Denied 3.6%
Outcome breakdown
OutcomeShare
Certified92.0%
Cert-withdrawn0.2%
Withdrawn4.3%
Denied3.6%
Certified92.0%
Cert-withdrawn0.2%
Withdrawn4.3%
Denied3.6%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Bioinfo Systems, LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20109
FY201110
FY201241
FY201340
FY201473
FY201580
FY201660
FY201762
FY201882
FY201968
FY20204
FY20210
FY20220
FY20230
FY202413
FY20257
FY202613
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.